SARS-CoV-2 breakthrough infections after COVID-19 vaccination in patients with inflammatory bowel disease: a systematic review and meta-analysis.

van de Pol, Natasja; Pan, Qiuwei; Derikx, Lauranne A A P; Bakker, Linda; van der Woude, C Janneke; de Vries, Annemarie C

van de Pol, Natasja; Pan, Qiuwei; Derikx, Lauranne A A P; Bakker, Linda; van der Woude, C Janneke; de Vries, Annemarie C.

Afiliação

van de Pol N; Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Centre, Rotterdam, The Netherlands.
Pan Q; Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Centre, Rotterdam, The Netherlands.
Derikx LAAP; Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Centre, Rotterdam, The Netherlands.
Bakker L; Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Centre, Rotterdam, The Netherlands.
van der Woude CJ; Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Centre, Rotterdam, The Netherlands.
de Vries AC; Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Dr. Molewaterplein 40, Rotterdam 3015 CE, The Netherlands.

Therap Adv Gastroenterol ; 16: 17562848231174295, 2023.

Article em En | MEDLINE | ID: mdl-37461739

Palavras-chave

COVID-19; Inflammatory Bowel Disease; SARS-CoV-2; breakthrough infection

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Guideline / Prognostic_studies / Systematic_reviews Idioma: En Revista: Therap Adv Gastroenterol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google